Key points are not available for this paper at this time.
The addition of abiraterone acetate and prednisone to androgen-deprivation therapy significantly increased overall survival and radiographic progression-free survival in men with newly diagnosed, metastatic, castration-sensitive prostate cancer. (Funded by Janssen Research and Development; LATITUDE ClinicalTrials.gov number, NCT01715285 .).
Building similarity graph...
Analyzing shared references across papers
Loading...
Karim Fizazi
NamPhuong Tran
Luis Fein
New England Journal of Medicine
Université Paris-Sud
Instituto de Oncología de Rosario
Building similarity graph...
Analyzing shared references across papers
Loading...
Fizazi et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69d951dec7f0c3ae80a3cf01 — DOI: https://doi.org/10.1056/nejmoa1704174